| Simvastatin |
NCT03011931 |
Completed |
Early Phase 1 |
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] |
Celiac Disease |
https://ClinicalTrials.gov/show/NCT03011931 |
| Simvastatin |
NCT04178980 |
Not yet recruiting |
Phase 1 |
Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis |
Simvastatin Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04178980 |
| Simvastatin |
NCT03324425 |
Recruiting |
Phase 2 |
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer |
Breast Cancer Stage IV |
https://ClinicalTrials.gov/show/NCT03324425 |
| Simvastatin |
NCT01702246 |
Completed |
Phase 1|Phase 2 |
Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease |
Sickle Cell Disease |
https://ClinicalTrials.gov/show/NCT01702246 |
| Simvastatin |
NCT04183387 |
Completed |
Phase 2 |
Simvastatin in Uveitis |
Uveitis |
https://ClinicalTrials.gov/show/NCT04183387 |
| Simvastatin |
NCT02061397 |
Active, not recruiting |
Phase 1|Phase 2 |
Safety of Simvastatin in LAM and TSC |
Lymphangioleiomyomatosis|Tuberous Sclerosis Complex |
https://ClinicalTrials.gov/show/NCT02061397 |
| Simvastatin |
NCT01771198 |
Terminated |
Phase 2 |
Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment |
Rhinosinusitis |
https://ClinicalTrials.gov/show/NCT01771198 |
| Simvastatin |
NCT02096588 |
Active, not recruiting |
Phase 2 |
Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin |
Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer |
https://ClinicalTrials.gov/show/NCT02096588 |
| Simvastatin |
NCT03896217 |
Recruiting |
Phase 2 |
Simvastatin in Secondary Progressive Multiple Sclerosis |
Secondary Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03896217 |
| Simvastatin |
NCT03329118 |
Unknown status |
Phase 1 |
Drug-drug Interaction Between Simvastatin and SHR3824 |
Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT03329118 |
| Simvastatin |
NCT02197234 |
Active, not recruiting |
Phase 1 |
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC |
Non Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02197234 |
| Simvastatin |
NCT03131726 |
Recruiting |
Phase 3 |
Treatment of Graves´Ophthalmopathy With Simvastatin (GO-DS) |
Graves Ophthalmopathy|Thyroid Associated Ophthalmopathy|Thyroid Associated Orbitopathy |
https://ClinicalTrials.gov/show/NCT03131726 |
| Simvastatin |
NCT01160978 |
Completed |
Phase 2|Phase 3 |
Donor Simvastatin Treatment in Organ Transplantation |
Heart Failure|Respiratory Failure|Liver Failure|Kidney Failure|Transplantation |
https://ClinicalTrials.gov/show/NCT01160978 |
| Simvastatin |
NCT01266434 |
Completed |
Phase 3 |
The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma |
Asthma |
https://ClinicalTrials.gov/show/NCT01266434 |
| Simvastatin |
NCT02433535 |
Withdrawn |
Phase 2 |
Trial of Simvastatin for the Treatment of Severe Asthma |
Severe Asthma |
https://ClinicalTrials.gov/show/NCT02433535 |
| Simvastatin |
NCT02161822 |
Active, not recruiting |
Phase 2 |
Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients |
Adenocarcinoma of Rectum |
https://ClinicalTrials.gov/show/NCT02161822 |
| Simvastatin |
NCT03247400 |
Unknown status |
Phase 1|Phase 2 |
The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo |
Non-segmental Vitiligo |
https://ClinicalTrials.gov/show/NCT03247400 |
| Simvastatin |
NCT01561482 |
Withdrawn |
Phase 2 |
Study of Metformin With Simvastatin for Men With Prostate Carcinoma |
Prostate Carcinoma |
https://ClinicalTrials.gov/show/NCT01561482 |
| Simvastatin |
NCT03775070 |
Recruiting |
Phase 2 |
Simvastatin Therapy in Patients With Dilated Cardiomyopathy. |
Dilated Cardiomyopathy |
https://ClinicalTrials.gov/show/NCT03775070 |
| Simvastatin |
NCT03571802 |
Not yet recruiting |
Phase 4 |
Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG) |
Obesity|Hyperlipidemias |
https://ClinicalTrials.gov/show/NCT03571802 |
| Simvastatin |
NCT02946424 |
Recruiting |
Phase 2 |
Simvastatin to Prevent SCI-Induced Bone Loss |
Spinal Cord Injuries|Osteoporosis |
https://ClinicalTrials.gov/show/NCT02946424 |
| Simvastatin |
NCT01073007 |
Completed |
Phase 4 |
Stroke Treatment With Acute Reperfusion and Simvastatin |
Stroke, Acute |
https://ClinicalTrials.gov/show/NCT01073007 |
| Simvastatin |
NCT02815722 |
Completed |
Phase 1 |
The Drug-drug Interaction of SP2086 and Simvastatin |
Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02815722 |
| Simvastatin |
NCT04301271 |
Recruiting |
Phase 2 |
Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression |
Depressive Disorder, Major|Obesity |
https://ClinicalTrials.gov/show/NCT04301271 |
| Simvastatin |
NCT03654053 |
Not yet recruiting |
Phase 3 |
Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis |
Cirrhosis |
https://ClinicalTrials.gov/show/NCT03654053 |
| Simvastatin |
NCT03402204 |
Completed |
Phase 3 |
Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS |
Ischemic Stroke |
https://ClinicalTrials.gov/show/NCT03402204 |
| Simvastatin |
NCT04021498 |
Recruiting |
Phase 3 |
Simvastatin in the Prevention of Recurrent Pancreatitis |
Pancreatitis Relapsing |
https://ClinicalTrials.gov/show/NCT04021498 |
| Simvastatin |
NCT01654562 |
Terminated |
Phase 1|Phase 2 |
The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia |
Choroideremia |
https://ClinicalTrials.gov/show/NCT01654562 |
| Simvastatin |
NCT01821027 |
Completed |
Phase 1 |
A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Simvastatin in Healthy Volunteers |
Healthy |
https://ClinicalTrials.gov/show/NCT01821027 |
| Simvastatin |
NCT01147692 |
Completed |
Phase 1 |
A Drug Interaction Study of Simvastatin and Albiglutide |
Diabetes Mellitus, Type 2 |
https://ClinicalTrials.gov/show/NCT01147692 |
| Simvastatin |
NCT01952288 |
Completed |
Phase 4 |
Simvastatin for mTBI |
TBI-Traumatic Brain Injury |
https://ClinicalTrials.gov/show/NCT01952288 |
| Simvastatin |
NCT04044417 |
Completed |
Phase 4 |
Curcumin-Simvastatin-EDTA in the Treatment of Periodontitis |
Periodontitis |
https://ClinicalTrials.gov/show/NCT04044417 |
| Simvastatin |
NCT03400475 |
Completed |
Phase 2 |
Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis |
Peri-implant Mucositis |
https://ClinicalTrials.gov/show/NCT03400475 |
| Simvastatin |
NCT03403972 |
Completed |
Phase 1 |
Evaluate the Effects of the Environmental Change in Intestine by Antibiotics on the Pharmacokinetic Characteristics of Simvastatin in Healthy Male Volunteers |
Simvastatin Pharmacokinetics and Gut Microbiome |
https://ClinicalTrials.gov/show/NCT03403972 |
| Simvastatin |
NCT03086291 |
Recruiting |
Phase 1 |
A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy |
Stomach Cancer |
https://ClinicalTrials.gov/show/NCT03086291 |
| Simvastatin |
NCT02817243 |
Unknown status |
Phase 1 |
The DDI Study of SP2086 and Simvastatin |
Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02817243 |
| Simvastatin |
NCT01960140 |
Completed |
Phase 1 |
A Study of Baricitinib and Simvastatin in Healthy Participants |
Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01960140 |
| Simvastatin |
NCT03400826 |
Recruiting |
Phase 2 |
Effects of Simvastatin on Uterine Leiomyoma Size |
Fibroid Uterus|Fibroid Tumor|Leiomyoma|Fibromyoma|Leiomyoma, Uterine |
https://ClinicalTrials.gov/show/NCT03400826 |
| Simvastatin |
NCT02447601 |
Completed |
Phase 1 |
Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects |
Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT02447601 |
| Simvastatin |
NCT01642862 |
Terminated |
Phase 1 |
Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration |
Celiac Disease |
https://ClinicalTrials.gov/show/NCT01642862 |
| Simvastatin |
NCT02548936 |
Unknown status |
Early Phase 1 |
Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE |
Atherosclerosis |
https://ClinicalTrials.gov/show/NCT02548936 |
| Simvastatin |
NCT01167933 |
Completed |
Phase 1 |
Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Conditions |
Healthy |
https://ClinicalTrials.gov/show/NCT01167933 |
| Simvastatin |
NCT01167894 |
Completed |
Phase 1 |
Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting Condition |
Healthy |
https://ClinicalTrials.gov/show/NCT01167894 |
| Simvastatin |
NCT03771053 |
Recruiting |
Not Applicable |
The Effect of Simvastatin Combined With Ezetimibe in Patients With Stable Angina and Diabetes |
Coronary Heart Disease |
https://ClinicalTrials.gov/show/NCT03771053 |
| Simvastatin |
NCT01999309 |
Unknown status |
Phase 3 |
Simvastatin Addition for Patients With Recent-onset Schizophrenia |
Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder|Psychosis NOS |
https://ClinicalTrials.gov/show/NCT01999309 |
| Simvastatin |
NCT03387670 |
Recruiting |
Phase 3 |
Multiple Sclerosis-Simvastatin Trial 2 |
Secondary Progressive Multiple Sclerosis (SPMS) |
https://ClinicalTrials.gov/show/NCT03387670 |
| Simvastatin |
NCT00994773 |
Completed |
Phase 1 |
Simvastatin for the Treatment of Chronic Hepatitis B |
Hepatitis B |
https://ClinicalTrials.gov/show/NCT00994773 |
| Simvastatin |
NCT03419429 |
Completed |
Phase 4 |
Simvastatin Gel With Perforated Resorbable Membranes in Treatment of Intrabony Defects in Chronic Periodontitis |
Chronic Periodontitis |
https://ClinicalTrials.gov/show/NCT03419429 |
| Simvastatin |
NCT00935259 |
Completed |
Phase 1 |
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED) |
Hypercholesterolemia, Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00935259 |
| Simvastatin |
NCT02886299 |
Completed |
Phase 4 |
Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis |
Fenofibrate/Simvastatin Comparison |
https://ClinicalTrials.gov/show/NCT02886299 |
